Clinical Trial Update: Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cyclobenzaprine HCl extended-release 15 mg to placebo for cervical and/or lower back pain due to muscle spasms of local origin; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Neck Pain

Drugs mentioned

• Cyclobenzaprine HCl Extended Release 15 mg (cyclobenzaprine)

Snippet

Sponsor: Takeda | Conditions: Neck Pain, Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2019-04-08